Chemo-profiling and exploring therapeutic potential of Momordica dioica Roxb. ex Willd. for managing metabolic related disorders: In-vitro studies, and docking based approach

J Ethnopharmacol. 2024 Sep 15:331:118351. doi: 10.1016/j.jep.2024.118351. Epub 2024 May 15.

Abstract

Ethnopharmacological relevance: Momordica dioica Roxb. ex Willd. (M. dioica Roxb.) a nutritious and therapeutic property rich crop of Cucurbitaceae plant family. In various folklore medicine including Ayurveda fruits are used to treat several metabolic related disorders i.e., hyperglycemia, hyperlipidemia, diabetes, obesity etc. Furthermore, traditionally it is used to treat fever, inflammation, ulcer, skin diseases, haemorrhoids, hypertension and also employed as cardioprotective, hepatoprotective, analgesic, diuretic.

Aim of the study: This study focuses to explore the therapeutic potential of Momordica dioica Roxb. ex Willd. through in-vitro and in-silico approach for managing hyperlipidemia, hyperglycemia and related metabolic disorders along with its phytochemical profiling for quality evaluation and validation of traditional claim.

Materials and methods: The present study was carried out on hydroalcohol extract of dried leaf and fruit of Momordica dioica. In-vitro antioxidant potential using DPPH and Nitric oxide scavenging assay along with in-vitro enzyme inhibitory potential against α-amylase, α-glucosidase, and pancreatic lipase enzymes was studied. The bioactive metabolites were identified from the most potent bioactive extract by analysis with LC-QTOF-MS and also studied their role to lessen the metabolic related disorder through in-silico approaches.

Results: The results confirmed that the fruit extract is more active to possess antioxidant and prominent enzyme inhibition potential compared to the leaf. Sixteen identified metabolites in M. dioica Roxb. fruits may be responsible for the therapeutic potential related to metabolic related disorder. The in-silico study of the identified phytomolecules against α-amylase, α-glucosidase and pancreatic lipase showed significant docking scores ranging from -9.8 to -5.5, -8.3 to -4.8 and -8.3 to -6 respectively.

Conclusion: The current study illustrated that M. dioica Roxb., a traditionally important plant is potential against metabolic related disorders. Phytocomponents present in the fruit extract may be responsible for antioxidant as well as the enzymes' inhibitory potential. Thus, fruits of M. dioica Roxb. will be useful as alternative therapeutics for treatment of hyperlipidemia, hyperglycemia and related metabolic disorders.

Keywords: Metabolite profiling; Molecular docking; Momordica dioica Roxb. ex wild.; Pancreatic lipase; α-amylase; α-glucosidase.

MeSH terms

  • Antioxidants* / chemistry
  • Antioxidants* / pharmacology
  • Fruit* / chemistry
  • Glycoside Hydrolase Inhibitors / pharmacology
  • Lipase / antagonists & inhibitors
  • Lipase / metabolism
  • Metabolic Diseases / drug therapy
  • Molecular Docking Simulation*
  • Momordica / chemistry
  • Phytochemicals / analysis
  • Phytochemicals / chemistry
  • Phytochemicals / pharmacology
  • Phytochemicals / therapeutic use
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacology
  • Plant Extracts* / therapeutic use
  • Plant Leaves / chemistry
  • alpha-Amylases / antagonists & inhibitors
  • alpha-Amylases / metabolism
  • alpha-Glucosidases / metabolism

Substances

  • Plant Extracts
  • Antioxidants
  • Phytochemicals
  • alpha-Amylases
  • alpha-Glucosidases
  • Lipase
  • Glycoside Hydrolase Inhibitors